Market Overview

US Stock Futures Down Ahead Of International Trade Data

US Stock Futures Down Ahead Of International Trade Data
Related FDX
FedEx's Q3 Shows Upward Earnings Trajectory, Stifel Says In Upgrade
5 Biggest Price Target Changes For Wednesday
FedEx ticks lower despite upbeat results but analysts sing praises (Seeking Alpha)
Related PEP
Barron's Picks And Pans: Altria, Apple, PepsiCo, Target And More
Chevron, Pepsi, And 2 Other Stocks In Downtrends This Week
Dividend Sensei's Portfolio Update 27: When Bombshells Go Off, You Adapt Or Die (Seeking Alpha)

Pre-open movers

US stock futures traded lower in early pre-market trade. Data on international trade for August will be released at 8:30 a.m. ET. Futures for the Dow Jones Industrial Average dropped 29 points to 16,630.0, while the Standard & Poor's 500 index futures fell 4.50 points to 1,970.25. Futures for the Nasdaq 100 index slipped 13.25 points to 4,298.00.

A Peek Into Global Markets

European markets were mostly higher today, with the Spanish Ibex Index gaining 0.63 percent, STOXX Europe 600 Index jumping 0.37 percent and German DAX 30 index gaining 0.73 percent. French CAC 40 Index rose 0.66 percent and London's FTSE 100 Index fell 0.02 percent.

In Asian markets, Japan's Nikkei Stock Average rose 1 percent, Hong Kong's Hang Seng Index fell 0.10 percent and India's BSE Sensex climbed 0.55 percent.

Broker Recommendation
Analysts at Stifel Nicolaus upgraded FedEx Corporation (NYSE: FDX) from Hold to Buy.

FedEx shares rose 3.05 percent to close at $149.96 on Monday.

Breaking news

  • Shares of PepsiCo, Inc. (NYSE: PEP) gained over 3 percent in pre-market trading after the company reported better-than-expected results for its third quarter on Tuesday. To read the full news, click here.
  • Applied DNA Sciences Inc (NASDAQ: APDN) announced its collaboration agreement with Security Marketing Resource, a California-based marketing and online training organization specializing in the security sector. To read the full news, click here.
  • SAGE Therapeutics Inc (NASDAQ: SAGE) today announced it has initiated dosing in a Phase 1 single ascending dose trial evaluating SAGE-217 in healthy volunteers. To read the full news, click here.
  • Skyworks Solutions Inc (NASDAQ: SWKS) and PMC-Sierra, Inc. (NASDAQ: PMCS) today announced a definitive agreement under which Skyworks will acquire PMC for $10.50 per share in an all-cash transaction valued at approximately $2 billion. To read the full news, click here.

Posted-In: Stifel Nicolaus US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (FDX + APDN)

View Comments and Join the Discussion!